Guangdong Biolight Meditech Co., Ltd.
Shenzhen Stock Exchange 300246.SZ
Guangdong Biolight Meditech Co., Ltd. Price to Book Ratio (P/B) on January 14, 2025: 1.25
Guangdong Biolight Meditech Co., Ltd. Price to Book Ratio (P/B) is 1.25 on January 14, 2025, a -37.85% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
Guangdong Biolight Meditech Co., Ltd. 52-week high Price to Book Ratio (P/B) is 11.33 on December 20, 2024, which is 806.15% above the current Price to Book Ratio (P/B).
-
Guangdong Biolight Meditech Co., Ltd. 52-week low Price to Book Ratio (P/B) is 1.07 on February 07, 2024, which is -14.36% below the current Price to Book Ratio (P/B).
-
Guangdong Biolight Meditech Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 1.41.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 300246.SZ
| CEO | Mr. Jinyuan Yan |
| IPO Date | July 19, 2011 |
| Location | China |
| Headquarters | No. 2 Innovation First Road |
| Employees | 1,419 |
| Sector | Health Care |
| Industries | |
Description
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email